Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
50.78 USD | -1.02% | +1.33% | +4.84% |
05-15 | HC Wainwright Adjusts Korro Bio's Price Target to $100 From $115, Keeps Buy Rating | MT |
05-14 | Korro Bio Q1 Net Loss Shrinks; Kemi Olugemo Appointed as Chief Medical Officer | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.84% | 476M | |
+47.23% | 54.63B | |
-6.74% | 39.92B | |
+37.07% | 38.82B | |
+13.27% | 26.86B | |
-11.17% | 26.22B | |
-21.60% | 18.78B | |
+25.11% | 12.21B | |
+0.53% | 12.16B | |
+25.57% | 11.94B |
- Stock Market
- Equities
- KRRO Stock
- News Korro Bio, Inc.
- Chardan Downgrades Frequency Therapeutics to Neutral From Buy